The effects of duloxetine on β-actin stress response in rat brain;A duloxetin hatása a β-aktin stresszválaszra patkány agyban

Neuropsychopharmacologia Hungarica

Volumn 12, Issue 1, 2010, Pages 301-307

  Szabina, Szücs ^a   Magdolna, Pákáski ^a   Ágnes, Domokos ^a   János, Kálmán ^a,a   Sára, Kálmán ^a   Dénes, Garab ^a   Botond, Penke ^b   Gyula, Szabó ^c   Zoltán, Janka ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Pszichiatriai Klinika   (Hungary)

^c NONE   (Hungary)

Author keywords

actin; Alzheimer's disease; Amyloid precursor protein; Duloxetine; Immobilization stress; Mitogen activated protein kinase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA ACTIN; DULOXETINE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; IMMOBILIZATION STRESS; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; RNA PURIFICATION; WESTERN BLOTTING;

ACTINS; ADRENERGIC UPTAKE INHIBITORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEURONAL PLASTICITY; NOREPINEPHRINE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; THIOPHENES;

EID: 77951548836     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bodnoff SR, Humphreys AG, Lehman JC, Diamond DM, Rose GM, Meaney MJ: Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 1995; 15:61-69.
2. Bonefeld BE, Elfving B, Wegener G: Reference genes for normalization: A study of rat brain tissue. Synapse 2008; 62:302-309. (Pubitemid 351365003)
3. Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N, Almeida OF : The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry 2009; 14:95-105.
4. Charles E, Bouby-Serieys V, Thomas P, Clémant JP: Relation entre événements de vie, traumatismes et démence; étude ouverte portant sur 565 patients déments. L'Encéphale 2006; 32:746-752. (Pubitemid 44739893)
5. Chen Y, Dube CM, Rice CJ, Baram TZ: Rapid loss of dendritic spines after stress involves derangement of spine dynamics by corticotropin-releasing hormone. J Neurosci 2008; 28:2903-2911. (Pubitemid 351398866)
6. Delgado PL: Common pathways of depression and pain. J Clin Psychiatry 2004;65 (Suppl 12):16-19.
7. Duman RS: Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998; 44:324-335. (Pubitemid 28432643)
8. Duyckaerts C, Panchal M, Delatour B, Potier MC: Morphologic and molecular neuropathology of Alzheimer's disease. Ann Pharm Fr 2009; 67:127-135.
9. Garcia R: Stress, metaplasticity, and antidepressants. Curr Mol Med 2002; 2:629-638.
10. Gutala RV, Reddy PH: The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J Neurosci Meth 2004; 132:101-107.
11. Haass C, Selkoe DJ: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8:101-112. (Pubitemid 46432529)
12. Licinio J, Wong ML: Brain-derived neurotrophic factor (BDNF) in stress and affective disorders. Mol Psychiatry 2002; 7:519.
13. Lynch G, Rex CS, Gall CM: LTP consolidation: Substrates, explanatory power and functional significance. Neuropharmacology 2007; 52:12-23. (Pubitemid 46026832)
14. Magri F, Cravello L, Barili L, Sarra S, Cinchetti W, Salmoiraghi F, Micale G, Ferrari E: Stress and dementia: the role of the hypothalamicpituitary- adrenal axis. Aging Clin Exp Res 2006; 18:167-170. (Pubitemid 43833638)
15. Palmert MR, Usiak M, Mayeux R, Raskind M, Tourtellotte WW, Younkin SG: Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease. Neurology 1990; 40:1028-1034. (Pubitemid 20213966)
16. Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, Hartoutunian V: Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry 2006; 63:161-167. (Pubitemid 43213877)
17. Rosa ML, Guimarães FS, de Oliveira RM, Padovan CM, Pearson RC, Del Bel EA: Restraint stress induces beta-amyloid precursor protein mRNA expression in the rat basolateral amygdala. Brain Res Bull 2005; 65:69-75.
18. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP: Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in animal model. Behav Brain Res 2001; 120:87-95. (Pubitemid 32118151)
19. Seeman TE, McEwen BS, Singer BH, Albert MS, Rowe JW: Increase in Urinary Cortisol Excretion and Memory Declines. J Clin Endocrinol Metab 1997; 82:2458-2465.
20. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurment of protein using bicinchoninic acid. Anal Biochem 1985; 150:76-85.
21. Trivedi MH, Desaiah D, Ossanna MJ, Pritchett YL, Brannan SK, Detke MJ: Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. Int Clin Psychopharmacol 2008; 23:161-169. (Pubitemid 351535907)
22. Zhou J, Li L, Tang S, Cao X, Li Z, Li W, Li C, Zhang X: Effects of serotonin depletion on the hippocampal GR/MR and BDNF expression during the stress adaptation. Behav Brain Res 2008; 195:129-138.